Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre, randomised, double-blind, non-inferiority trial Prof John Burn, MDa,b Send email to john.burn@newcastle.ac.uk ∙ Dr Gillian M Borthwick, PhDa ∙ Faye Elliott, MScc ∙ Prof Finlay Macrae, MBBSd ∙ Kai Ren Ong, MDe ∙ Alison C Kraus, MDf ∙ et al.

Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre, randomised, double-blind, non-inferiority trial Prof John Burn, MDa,b Send email to john.burn@newcastle.ac.uk ∙ Dr Gillian M Borthwick, PhDa ∙ Faye Elliott, MScc ∙ Prof Finlay Macrae, MBBSd ∙ Kai Ren Ong, MDe ∙ Alison C Kraus, MDf ∙ et al. https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00114-7/fulltext?dgcid=raven_jbs_etoc_feature_langas